Warning: ini_set() has been disabled for security reasons in /home/elite/public_html/wp-includes/default-constants.php on line 64
June 11, 2021 - Elite Stock Chat

Day: June 11, 2021

DNMR – ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Danimer Scientific, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DNMR

New York, June 11, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Danimer Scientific, Inc. (NYSE: DNMR) between October 5, 2020 and May 4, 2021, inclusive (the “Class Period”), of the important July 13, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Danimer Scientific securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Danimer Scientific class action, go to http://www.rosenlegal.com/cases-register-2065.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 13, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Danimer Scientific had overstated and/or misstated the biodegradability and environmentally-friendly nature of its Nodax product, particularly in oceans and landfills; (2) defendants misrepresented the size of Danimer Scientific’s facilities, production capacity and actual production amounts, and costs; (3) defendants misrepresented Danimer Scientific’s growth, financial results, and financial projections; (4) Danimer Scientific had deficient internal controls; and (5) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Danimer Scientific class action, go to http://www.rosenlegal.com/cases-register-2065.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

SOURCE Rosen Law Firm, P.A.

Related Links

www.rosenlegal.com

AAPL – Apple tightens legal request rules after Justice Department targets lawmakers

The logo of Apple (AAPL) is seen in Los Angeles, California, United States, April 22, 2016. REUTERS/Lucy Nicholson/File Photo

(Reuters) – Apple Inc on Friday said it has tightened some of its rules for responding to legal requests after the U.S. Justice Department during Donald Trump’s presidency subpoenaed it for information on Democratic lawmakers.

Apple said it recently instituted a limit of 25 identifiers such as email addresses or phone numbers per legal request.

The Cupertino, California-based company said it received a subpoena from the Justice Department in February 2018 for information on 109 identifiers made up of 73 phone numbers and 36 email addresses, but that it did not release content such as emails and pictures to prosecutors.

The New York Times on Thursday reported that federal prosecutors subpoenaed Apple and other companies as part of an investigation searching for the sources behind news media reports about contacts between Trump’s associates and Russia.

The investigation targeted at least two Democrats on the House of Representatives Intelligence Committee, aides and family members, including one minor, the Times reported.

Apple said that it had no way to tell what the nature of the investigation was and released only basic “account subscriber information” such as names, addresses, email addresses and telephone numbers, as well as connection logs and IP addresses.

Apple said that it did not provide data showing to whom or when messages of any kind were sent.

Justice Department Inspector General Michael Horowitz said on Friday he will investigate the department’s efforts under Trump to seize the communications data of lawmakers and members of the news media.

PRVB – SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Provention Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2021 – PRVB

New York, New York–(Newsfile Corp. – June 11, 2021) –  The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Provention Bio, Inc. (“Provention Bio”) (NASDAQ: PRVB) between November 2, 2020 and April 8, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the District of New Jersey. To get more information go to:

https://www.zlk.com/pslra-1/provention-bio-inc-loss-submission-form?prid=16825&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

Cannot view this image? Visit: https://www.elitestockchat.com/wp-content/uploads/2021/06/87374_586284_logo.jpg

Provention Bio, Inc. NEWS – PRVB NEWS

CASE DETAILS: According to the filed complaint: (i) the teplizumab Biologics License Application (“BLA”) was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA’s approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Provention Bio, you have until July 20, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Provention Bio securities between November 2, 2020 and April 8, 2021, you may be entitled to compensation without payment of any out-of-pocket costs or fees.

PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form https://www.zlk.com/pslra-1/provention-bio-inc-loss-submission-form?prid=16825&wire=5 or call 212-363-7500 to discuss the case with Joseph E. Levi, Esq.

WHY LEVI & KORSINSKY: Levi & Korsinsky have a proven track record of winning cases worth hundreds of millions of dollars for shareholders over a 20-year period. We represent and fight for shareholders who have been wronged by corporations.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. The Firm’s Founding Partners, Joseph Levi and Eduard Korsinsky, have been representing shareholders and institutional clients for almost 20 years and have achieved remarkable results for clients in the U.S. and internationally. The firm, with more than 80 employees, is committed to fostering, cultivating and preserving a culture of diversity, equity and inclusion for employees and those that we represent. Our attorneys have extensive expertise representing investors in securities litigation with a track record of recovering hundreds of millions of dollars in cases. Levi & Korsinsky was ranked in Institutional Shareholder Services’ (“ISS”) SCAS Top 50 Report for 7 years in a row as a top securities litigation firm in the United States. The SCAS Top 50 Report identifies the top plaintiffs’ securities law firms in the country, and year after year, ISS has recognized Levi & Korsinsky as a leading firm in the area of securities class action litigation.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/87374

info

WPG – ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Washington Prime Group Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important July 23 Deadline in Securities Class Action – WPG

New York, New York–(Newsfile Corp. – June 11, 2021) – WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Washington Prime Group Inc. (NYSE: WPG) between November 5, 2020 and March 4, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 23, 2021.

SO WHAT: If you purchased Washington Prime Group securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Washington Prime Group class action, go to http://www.rosenlegal.com/cases-register-2102.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 23, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Washington Prime Group’s financial condition was deteriorating substantially; (2) as a result, there was substantial uncertainty about the Company’s ability to meet its capital structure obligations as they became due; and (3) as a result of the foregoing, defendants’ positive statements about Washington Prime Group’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Washington Prime Group class action, go to http://www.rosenlegal.com/cases-register-2102.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/87373

info

NVDA – NVIDIA Acquiring DeepMap Vehicle Cartography Startup

On Friday, NVIDIA (NASDAQ:NVDA) ended its week with the announcement of a pending acquisition. The company said it had reached an agreement to acquire DeepMap, a privately held business that specializes in creating high-definition maps to help guide autonomous cars.

NVIDIA did not reveal the price it has agreed to pay for the company.

It did say that DeepMap will help improve the mapping and localization functions of NVIDIA DRIVE, its software-defined autonomous operations system. 

Car speeding along a highway near dawn or dusk.

Image source: Getty Images.

NVIDIA clearly has long-range hopes for its asset-to-be. The company quoted its vice president and general manager of automotive Ali Kani as saying that, “DeepMap is expected to extend our mapping products, help us scale worldwide map operations and expand our full self-driving expertise.”

While NVIDIA is primarily known among the public as a maker of computer graphics cards, over the past few years it has leveraged its expertise to push assertively into self-driving systems.

Yet although much capital has been expended in developing such systems, not to mention accompanying hardware, the world is still quite some distance away from full autonomy. At the moment, according to the Society of Automotive Engineers’ benchmark levels of autonomy scale, experts say we are just at, or a bit below, Level 3 (Level 5 is 100% autonomous operation).

Level 3 is defined as when “[automated] features can drive the vehicle under limited conditions and will not operate unless all required conditions are met.”

Considering that, NVIDIA’s deal looks like a good chess move that could help the company produce meaningful results well down the road if properly integrated and utilized.

Investors like the DeepMap deal. On Friday, they traded NVIDIA stock up by 2.3%, which trounced the 0.2% increase of the S&P 500 index.

 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

PCT – PureCycle Update

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PureCycle To Contact Him Directly To Discuss Their Options

New York, New York–(Newsfile Corp. – June 11, 2021) –  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PureCycle Technologies, Inc. (“PureCycle” or the “Company”) (NASDAQ: PCT) and reminds investors of the July 12, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you suffered losses exceeding $50,000 investing in PureCycle stock or options between November 16, 2020 and May 5, 2021 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/PCT.

Cannot view this image? Visit: https://www.elitestockchat.com/wp-content/uploads/2021/06/87359_68fe032fb43e7b80_001.jpg

There is no cost or obligation to you.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.

As detailed below, the lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that PureCycle had: (1) previously brought six other businesses public only to have each implode thereafter, “resulting in 2 bankruptcies, 3 delistings, and 1 acquisition after a ~95% decline[,]” with “[o]ver $760 million in public shareholder capital [being] incinerated in the process”; (2) “based their financial projections” in those other failed companies on “‘wild ass guessing,’ [bringing] companies public far too early, and [having] deceived investors”; and (3) only brought PureCycle public in order to permit that same spurious management team to “collectively position themselves to clear ~$90 million in cash and tradable shares before the company generates a single dime in revenue.”

In response to this news, the price of PureCycle common stock declined by more than 40%, or approximately $10 per share.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding PureCycle’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/87359

info

ATER – Aterian Update

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Aterian To Contact Him Directly To Discuss Their Options

New York, New York–(Newsfile Corp. – June 11, 2021) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aterian, Inc. (“Aterian” or the “Company”) (NASDAQ: ATER) and reminds investors of the July 12, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you suffered losses exceeding $50,000 investing in Aterian stock or options between December 1, 2020 and May 3, 2021 and would like to discuss your legal rights, call Faruqi & Faruqi partner James Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ATER.

Cannot view this image? Visit: https://www.elitestockchat.com/wp-content/uploads/2021/06/87358_f676e97b64cdca26_001.jpg

There is no cost or obligation to you.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.

As detailed below, the lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company’s organic growth is plummeting; (2) the Company’s recent, self-lauded acquisitions were overpayments for flawed assets from questionable sources; (3) Aterian’s purported artificial intelligence software is a flawed product that lacks customer interest; (4) Aterian uses rebate programs and paid or artificial reviews to pump up their product offerings; (5) as a result, the Company’s public statements were materially false and misleading at all relevant times.

On May 4, 2021, Culper Research published a scathing report entitled: “Aterian (ATER): Bought from Felons & Fraudsters, Sold to You.” In this report, Culper wrote that: “the Company has ties to convicted criminals and is promoting what we believe is an over-hyped ‘AI’ narrative and a string of garbage acquisitions to mask the failure of its already ill-conceived core business.”

Culper continued that: “Aterian has been largely unsuccessful in convincing other Amazon sellers to pay for its ‘AIMEE’ AI platform, and at least 5 former employees and a former customer have expressed doubts regarding AIMEE’s legitimacy.”

Culper further wrote: “[w]e believe that there are serious problems with Aterian’s claims to maintain strong organic growth and to drive M&A synergies: to us, neither of these appears to be the case. . . . In our view, this suggests not only that Aterian is unable to growth EBITDA at acquired businesses, but that its core business is also failing to produce.”

On this news, the price of Aterian stock fell from its May 3, 2021 close of $20.66 to a May 5, 2021 close of $15.72 per share, a two-day drop of $4.94 per share or approximately 24%.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Aterian’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/87358

info